Research Programmes

SPAIN CCSS (Spanish Childhood Cancer Survivor Study)

Duration
2011- 2014 as a subtask of Procardio (to be extended afterwards)
Coordinator
Elisabeth Cardis and Eileen Pernot
Funded by
European Union/Euratom: European Seventh Framework Programme
Childhood cancer is the main cause of disease related death in children, with leukaemia and brain cancer being the most frequent types of childhood tumours diagnosed. Besides genetic conditions and exposure to ionising radiation, its causes remain largely unknown although many environmental risk factors are suspected.

Survival at 5 years after childhood cancers across Europe is heterogeneous. In Spain, it reached 77 % for cases diagnosed between 2000 and 2004. Improvements in treatments during the last decades have substantially increased the childhood cancer survival rates and it is estimated that there are 300,000 to 500,000 childhood cancer survivors currently alive in Europe.

Improvements in survival have however been accompanied by a parallel increase in the appearance of late adverse effects due to cancer treatments. The study of the effects of such treatments in children is of particular interest because they were treated when organs and physiological systems were still immature and they potentially have many years of life – including reproductive life – in front of them.

Effects of cancer treatment, including second cancers, other chronic diseases and permanent or chronic disability later in life represent a substantial burden on affected individuals, families, and health services. Medical guidelines on the long term follow-up of childhood cancer survivors are available and cover many potential problems which can arise after cancer treatments (thyroid dysfunction, growth problems, fertility, psychosocial problems, etc) but questions remain open about the long-term effects of treatment and optimisation of treatment for the future.

CREAL aims to establish a Spanish cohort of childhood cancer survivors (Study of the Spanish survivors of childhood cancer [SPAIN-CCSS] suitable for prospective follow-up in the longer term. This cohort will allow the investigation of possible adverse health outcome and late mortality after chemotherapy and radiotherapy, with the ultimate objective of optimising cancer treatment in the future. Following the set-up of SPAIN-CCSS, a study based on this cohort will be conducted in the framework of ProCardio in order to investigate in particular cardiovascular disease outcomes.

 

Please refer to CREAL's webpage related to ProCardio for further information click here.

Our Team

Principal Investigator (PI)

Our Team

  • EILEEN PERNOT -
    EILEEN PERNOT -

Other projects

See Past Projects

MCC-Spain

Population based multicasecontrol study on common tumours in Spain

HELIX

Novel tools for integrating early-life environmental exposures and child health across Europe

EGG/EAGLE

Early Genetics Growth/Early Genetics and Lifecourse Epidemiology

PACE

Pregnancy and Childhood Epigenetics

LIFECYCLE

Early-life stressors and LifeCycle health

OMEGA-NET

Network on the Coordination and Harmonisation of European Occupational Cohorts

HARMONIC

Health effects of cArdiac fluoRoscopy and mOdern radIotherapy in paediatriCs

EPHOR

Exposome Project for Health and Occupational Research

Mobilise-D

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

COVICAT

Cohorte Covid-19 en Cataluña

EARLY-ADAPT

Signs of Early Adaptation to Climate Change

ATHLETE

Advancing Tools for Human Early Lifecourse Exposome Research and Translation

CONTENT

Cohort of COVID-19 in Spain: social dynamics, mental health and inequalities

EUCAN-Connect

A federated FAIR platform enabling large-scale analysis of high-value cohort data connecting Europe and Canada in personalized health

OBERON

An integrative strategy of testing systems for identification of EDs related to metabolic disorders

EXPANSE

EXposome Powered tools for healthy living in urbAN SEttings

AURORA 2021

Actionable eUropean ROadmap for early-life health Risk Assessment of micro- and nanoplastics

ONES

Fine Particle Matter, Fetal Growth, and Neurodevelopment: Examining Critical Windows of Susceptibility

AIR-NB

Pre-natal exposure to urban AIR pollution and pre- and post-Natal Brain development

NutinBrain

The role of seafood and nut consumption on human neurodevelopment from pregnancy to adolescence

UrbanKids

Urban and social environment and childhood obesity – a natural moving2health experiment

iGenCO

In-Depth Genomics and Cross-Omics Analysis for Undiagnosed Rare Diseases on a User-Friendly Collaborative Platform

CityExposomeCat

An Exposome Approach to Urban Health: Individualized Environmental Exposure Assessment in an Adults Population Cohort Study (GCAT)

TwinAir

Digital Twins Enabled Indoor Air Quality Management for Healthy Living

UBDPOLICY

The Urban Burden of Disease Estimation for POLICY Making

TOLIFE

Combining Artificial Intelligence and smart sensing TOward better management and improved quality of LIFE in chronic obstructive pulmonary disease

BWater

Drinking Water in Barcelona: Sustainability and Health Impact Assessment